As U.S. measles cases reach a 35-year high, the White House is trying to overhaul the childhood vaccine schedule—including plans to split MMR. How are leading medical societies reacting?

This episode examines controversial proposed changes to the U.S. childhood vaccine schedule amid a 35-year high in measles cases, along with medical society concerns about evidence and access. It also reviews positive phase 3 topline data for lysergide in generalized anxiety disorder, updated colorectal cancer screening guidance that now includes blood-based testing, and the CHIPS trial showing refrigerated platelets may safely extend storage to 21 days and improve access in rural and community hospitals.